Topic

obesity

14 articles

GLP-1 weight-loss drugs in Dubai: 5 numbers patients should check before starting

A practical UAE guide to GLP-1 weight-loss treatment, including eligibility, likely cost, timelines and regulator checks.

30 Sept 2026 · 3 min read

GLP-1 weight-loss drugs in Dubai: 5 numbers patients should check before starting

Rs 3.5 lakh obesity claim ruling puts UAE bariatric documentation under scrutiny

A Kerala claim dispute shows why UAE bariatric providers must document medical necessity before insurers classify surgery as weight control.

13 Sept 2026 · 3 min read

Rs 3.5 lakh obesity claim ruling puts UAE bariatric documentation under scrutiny

ESRI study of 2,400 adults exposes obesity messaging gap for UAE clinics and insurers

Irish data show the public still blames lifestyle for obesity. UAE operators need programmes that document clinical risk, cover benefits and reduce stigma.

8 Sept 2026 · 3 min read

ESRI study of 2,400 adults exposes obesity messaging gap for UAE clinics and insurers

AED 1,560 a month for Mounjaro in Dubai: what GLP-1 weight loss actually means

A Dubai-focused guide to GLP-1 weight-loss medication, with prices, eligibility, dosing and safety checks.

28 Aug 2026 · 3 min read

AED 1,560 a month for Mounjaro in Dubai: what GLP-1 weight loss actually means

UAE GLP-1 obesity care now hinges on 10,000-step compliance, Burjeel CMO says

GLP-1 drugs are changing UAE obesity care. Clinics, insurers and patients now need lifestyle tracking, clear eligibility and licensed dietetic support.

28 Aug 2026 · 3 min read

UAE GLP-1 obesity care now hinges on 10,000-step compliance, Burjeel CMO says

Burjeel CMO: GLP-1 obesity care in UAE now needs 10,000-step evidence

A Burjeel obesity adviser says GLP-1 drugs should be tied to diet, sleep and activity plans. Clinics and insurers need documented follow-up.

28 Aug 2026 · 3 min read

Burjeel CMO: GLP-1 obesity care in UAE now needs 10,000-step evidence

10,000 steps enter UAE obesity-drug reimbursement as Burjeel doctor says lifestyle care is required

GLP-1 demand is changing UAE obesity care. Clinics, insurers and patients now need documented lifestyle support, follow-up and coverage checks.

27 Aug 2026 · 3 min read

10,000 steps enter UAE obesity-drug reimbursement as Burjeel doctor says lifestyle care is required

UAE GLP-1 use rises as Burjeel doctor says drugs deliver 50% to 60% of weight-loss plan

GLP-1 demand is changing obesity care in the UAE. Clinics and insurers need documented diet, exercise and follow-up pathways.

27 Aug 2026 · 3 min read

UAE GLP-1 use rises as Burjeel doctor says drugs deliver 50% to 60% of weight-loss plan

Medcare reports 5 Moviva weight-loss cases in Dubai, testing demand for cash-pay obesity care

Medcare has introduced Moviva in Dubai. Clinics, insurers and patients need to judge price, eligibility and evidence.

26 Aug 2026 · 3 min read

Medcare reports 5 Moviva weight-loss cases in Dubai, testing demand for cash-pay obesity care

Medcare reports 4 Moviva weight-loss cases in Dubai as clinics face coverage and evidence questions

Medcare says Moviva is now in Dubai. Clinics, insurers and patients need to test pricing, eligibility and evidence before treating it as routine care.

25 Aug 2026 · 3 min read

Medcare reports 4 Moviva weight-loss cases in Dubai as clinics face coverage and evidence questions

Moviva reaches Dubai in 2026, with AED 30,000 weight-loss packages and limited coverage clarity

Medcare has introduced Moviva in Dubai. Clinics, insurers and patients now face evidence, pricing and follow-up questions.

25 Aug 2026 · 3 min read

Moviva reaches Dubai in 2026, with AED 30,000 weight-loss packages and limited coverage clarity

Finance & Investment

UAE obesity intervention could save $1.5 billion and add $51 billion to GDP by 2031

UAE obesity intervention could save $1.5 billion in healthcare costs and add $51 billion to GDP by 2031, per economic modelling published 1 June 2026. The projection reframes obesity as a direct fiscal issue for insurers and hospital operators.

11 Jun 2026 · 3 min read

UAE obesity intervention could save $1.5 billion and add $51 billion to GDP by 2031

Market IntelligenceBreaking

UAE investors chase $39.4 billion GLP-1 opportunity as local healthcare stocks lag

Gulf investors are piling into GLP-1 drug makers Novo Nordisk and Eli Lilly, targeting a $39.4 billion market even as UAE-listed healthcare stocks underperform broader indices by 8-12 percentage points.

7 Apr 2026 · 3 min read

UAE investors chase $39.4 billion GLP-1 opportunity as local healthcare stocks lag

Regulatory & Policy

MOHAP approves first oral GLP-1 pill for UAE's 32% obesity rate, May 2026 launch

MOHAP has approved the UAE's first oral GLP-1 obesity drug, with pharmacies stocking from May 2026. The pill targets a market that grew 41% year-on-year since 2023.

4 Apr 2026 · 3 min read

MOHAP approves first oral GLP-1 pill for UAE's 32% obesity rate, May 2026 launch